查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
次世代定序服务市场规模、份额和成长分析（按类型、技术、工作流程、最终用途、应用和地区划分）—2026-2033年产业预测
市场调查报告书
商品编码
1899132

次世代定序服务市场规模、份额和成长分析（按类型、技术、工作流程、最终用途、应用和地区划分）—2026-2033年产业预测

Next-Generation Sequencing Services Market Size, Share, and Growth Analysis, By Type (Human Genome Sequencing, Single Cell Sequencing), By Technology, By Workflow, By End Use, By Application, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球次世代定序服务市场规模预计在 2024 年达到 102.8 亿美元，从 2025 年的 125.8 亿美元成长到 2033 年的 634 亿美元，在预测期（2026-2033 年）内复合年增长率为 22.4%。

由于次世代定序(NGS) 技术在生物技术、医学诊断和病毒学等多个领域具有变革性影响，其全球市场正迅速扩张。这项先进的DNA测序技术能够快速且有效率地解码整个基因组，相比传统的桑格定序等方法具有显着优势。 NGS 的扩充性和高通量能力使其成为全球临床实验室分析和疾病诊断的重要组成部分。该技术还有助于加速药物基因组学领域的药物发现进程，增强对早期检测和个人化治疗至关重要的生物标记的识别。因此，NGS 在分子生物学和遗传学的发展以及从传统诊断到精准医疗的转变过程中发挥关键作用。

推动全球次世代定序服务市场发展的因素

在临床诊断技术不断进步的推动下，全球次世代定序（NGS）服务市场正经历显着成长。 NGS技术在法医学、生殖医学、个人化医疗、生物标记和诊断等领域的广泛应用，凸显了其多功能性和重要性。 NGS技术凭藉其分析准确性、高通量能力和成本效益，已成为临床检查室诊断遗传疾病的首选技术。这项创新技术不仅能够实现精准诊断，还能透过基因测序为罕见疾病管理提供有效途径。在此背景下，市场对NGS服务的需求持续成长，推动市场扩张和技术在多个领域的整合。

全球次世代定序服务市场面临的限制因素

全球次世代定序服务市场面临着与DNA定序固有的法律和伦理考量相关的许多挑战。这些复杂问题包括文化敏感度、可识别性问题、研究结果共用的影响、潜在的刻板印象、知情同意的充分性、污名化风险、整体性问题以及不同群体利益分配不均等。这些伦理困境对市场成长构成重大障碍，因为相关人员必须谨慎行事，因为在这种环境下，负责任且公平地使用定序技术所带来的影响和后果将受到严格审查。解决这些问题对于促进市场的未来发展至关重要。

次世代定序服务市场的全球趋势

全球次世代定序服务市场正见证着第三代定序技术的显着应用趋势，这些技术正在革新基因组分析中。以单分子定序方法为特征的这些进步，无需克隆扩增和聚合酵素链锁反应(PCR)，从而减少了传统方法中常见的误差。因此，利用单分子即时 (SMRT)定序、FRET定序和奈米孔定序的平台因其能够提供更长的读长并简化製备流程而备受关注。这一发展不仅提高了定序的准确性，而且使其能够在包括医学研究、诊断和个人化医疗在内的广泛领域中得到应用，从而推动了该领域的蓬勃发展。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

全球次世代定序服务市场规模（按类型和复合年增长率划分）（2026-2033 年）

  • 人类基因组定序
  • 单细胞定序
  • 微生物基因组定序
  • 基因调控服务
    • 小RNA定序
    • 晶片定序
    • 其他基于基因调控的服务
  • 动植物定序
  • 其他定序服务

全球次世代定序服务市场规模（依技术及复合年增长率划分）（2026-2033 年）

  • 合成定定序
  • 离子半导体定序
  • 奈米孔定序
  • 单分子即时定序
  • 其他技术

全球次世代定序服务市场规模（按工作流程和复合年增长率划分）（2026-2033 年）

  • 定序预处理
  • 定序
  • 数据分析

全球次世代定序服务市场规模（依最终用途划分）及复合年增长率（2026-2033 年）

  • 大学和其他研究机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

全球次世代定序服务市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

  • 诊断
  • 肿瘤学
  • 生殖医学
  • 感染疾病
  • 罕见遗传疾病
  • 其他的
  • 药物发现
  • 生物标记发现
  • 微生物遗传学、农业和动物研究
  • 其他用途

全球次世代定序服务市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Illumina, Inc.（USA）
  • Thermo Fisher Scientific Inc.（USA）
  • BGI Genomics Co., Ltd.（China）
  • Eurofins Scientific SE（Luxembourg）
  • QIAGEN NV（Netherlands）
  • Agilent Technologies, Inc.（USA）
  • PerkinElmer, Inc.（USA）
  • Macrogen, Inc.（South Korea）
  • Pacific Biosciences of California, Inc.（USA）
  • Oxford Nanopore Technologies plc（UK）
  • Novogene Co., Ltd.（China）
  • Psomagen, Inc.（USA）
  • 10x Genomics, Inc.（USA）
  • Takara Bio Inc.（Japan）
  • Zymo Research Corp.（USA）
  • CD Genomics（USA）
  • MedGenome Labs Pvt Ltd.（India）
  • Fulgent Genetics, Inc.（USA）
  • Personalis, Inc.（USA）

结论与建议

简介目录
Product Code: SQSG35A2092

Global Next-Generation Sequencing Services Market size was valued at USD 10.28 Billion in 2024 and is poised to grow from USD 12.58 Billion in 2025 to USD 63.4 Billion by 2033, growing at a CAGR of 22.4% during the forecast period (2026-2033).

The global market for next-generation sequencing (NGS) services is witnessing rapid expansion due to its transformative impact across various fields such as biotechnology, medical diagnostics, and virology. This advanced DNA sequencing technology enables the rapid and efficient sequencing of entire genomes, providing significant advantages over traditional methods like Sanger sequencing. Its scalability and high throughput capabilities make NGS essential in clinical laboratory analysis and disease diagnosis worldwide. The technology also facilitates accelerated drug discovery processes in pharmacogenomics and enhances the identification of biomarkers critical for early detection and individualized therapies. As a result, NGS plays a pivotal role in advancing molecular biology, genetics, and the evolution from conventional diagnosis to a precision medicine approach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next-Generation Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next-Generation Sequencing Services Market Segments Analysis

Global Next-Generation Sequencing Services Market is segmented by type, technology, workflow, end use, application and region. Based on type, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing and other technologies. Based on workflow, the market is segmented into pre-sequencing, sequencing and data analysis. Based on end use, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others. Based on application, the market is segmented into diagnostics, oncology, reproductive health, infectious diseases, rare genetic disorders, others, drug discovery, biomarker discovery, microbial genetics, agriculture, and animal research and other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market is experiencing significant growth fueled by ongoing advancements in clinical diagnostics. Various applications, including forensics, reproductive health, personalized medicine, biomarkers, and diagnostics, highlight the versatility and importance of NGS technology. Its analytical precision, high throughput capabilities, and cost-efficiency have established NGS as the preferred choice in clinical laboratories for diagnosing genetic disorders. This innovation not only facilitates accurate diagnoses but also presents a viable approach to managing rare diseases through genomic sequencing. As such, the demand for NGS services continues to rise, propelling market expansion and technological integration across numerous sectors.

Restraints in the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing Services market faces various challenges related to legal and ethical considerations inherent in DNA sequencing. These complex issues encompass cultural sensitivities, concerns about identifiability, the impact of sharing study results, potential stereotyping, the adequacy of informed consent, risk of stigmatization, matters of inclusion, and the unequal benefits to different groups. Together, these moral dilemmas create significant barriers to market growth, as stakeholders must navigate a landscape filled with scrutiny over the implications and consequences of utilizing sequencing technologies responsibly and equitably. Addressing these concerns is crucial for fostering the future development of the market.

Market Trends of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing Services market is experiencing a notable trend towards the adoption of third-generation sequencing technologies, which are revolutionizing genomic analysis. These advancements, characterized by single-molecule sequencing approaches, eliminate the need for clonal amplification and polymerase chain reaction (PCR), thereby reducing errors associated with these traditional methods. As a result, platforms utilizing Single-Molecule Real-Time (SMRT) sequencing, FRET sequencing, and Nanopore sequencing are gaining traction due to their ability to deliver longer read lengths and simplify preparatory workflows. This evolution not only enhances the accuracy of sequencing but also broadens applications across medical research, diagnostics, and personalized medicine, driving significant growth in the sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Next-Generation Sequencing Services Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Human Genome Sequencing
  • Single Cell Sequencing
  • Microbial Genome-Based Sequencing
  • Gene Regulation Services
    • Small RNA Sequencing
    • Chip Sequencing
    • Other Gene Regulation-Based Services
  • Animal & Plant Sequencing
  • Other Sequencing Services

Global Next-Generation Sequencing Services Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Nanopore Sequencing
  • Single-Molecule Real-Time Sequencing
  • Other Technologies

Global Next-Generation Sequencing Services Market Size by Workflow & CAGR (2026-2033)

  • Market Overview
  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Global Next-Generation Sequencing Services Market Size by End Use & CAGR (2026-2033)

  • Market Overview
  • Universities & Other Research Entities
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others

Global Next-Generation Sequencing Services Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Diagnostics
  • Oncology
  • Reproductive Health
  • Infectious Diseases
  • Rare Genetic Disorders
  • Others
  • Drug Discovery
  • Biomarker Discovery
  • Microbial Genetics, Agriculture, And Animal Research
  • Other Applications

Global Next-Generation Sequencing Services Market Size & CAGR (2026-2033)

  • North America (Type, Technology, Workflow, End Use, Application)
    • US
    • Canada
  • Europe (Type, Technology, Workflow, End Use, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Technology, Workflow, End Use, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Technology, Workflow, End Use, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Technology, Workflow, End Use, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Genomics Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Macrogen, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novogene Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psomagen, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research Corp. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CD Genomics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedGenome Labs Pvt Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fulgent Genetics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Personalis, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations